what is micro dose tirzepatide Microdosing Program 𝗪𝐡𝐲 𝐰𝐞 𝐥𝐨𝐯𝐞 𝐦𝐢𝐜𝐫𝐨-𝐝𝐨𝐬𝐢𝐧𝐠 𝐓𝐢𝐫𝐳𝐞𝐩𝐚𝐭𝐢𝐝𝐞/𝐒𝐞𝐦𝐚𝐠𝐥𝐮𝐭𝐢𝐝𝐞

Exenatide (marketed as Byetta and Bydureon in the UK) is a synthetic version of exendin-4 and was one of the first GLP-1 receptor agonists approved for clinical use in type 2 diabetes

The 0.25mg starting dose is designed for safety and tolerance rather than maximum efficacy

Because of these effects, GLP-1 has become a major focus in managing type 2 diabetes, obesity, and metabolic syndrome

Individual responses vary, and most patients do not experience clinically significant tachycardia

Thioctic Acid / Alpha-Lipoic Acid (2,500 mg) A versatile antioxidant that restores brightness and prevents damage

After interviewing doctors and meeting with specialists, I got a lot of answers to my many, many questions